HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RB1 gene inactivation by chromothripsis in human retinoblastoma.

Abstract
Retinoblastoma is a rare childhood cancer of the developing retina. Most retinoblastomas initiate with biallelic inactivation of the RB1 gene through diverse mechanisms including point mutations, nucleotide insertions, deletions, loss of heterozygosity and promoter hypermethylation. Recently, a novel mechanism of retinoblastoma initiation was proposed. Gallie and colleagues discovered that a small proportion of retinoblastomas lack RB1 mutations and had MYCN amplification [1]. In this study, we identified recurrent chromosomal, regional and focal genomic lesions in 94 primary retinoblastomas with their matched normal DNA using SNP 6.0 chips. We also analyzed the RB1 gene mutations and compared the mechanism of RB1 inactivation to the recurrent copy number variations in the retinoblastoma genome. In addition to the previously described focal amplification of MYCN and deletions in RB1 and BCOR, we also identified recurrent focal amplification of OTX2, a transcription factor required for retinal photoreceptor development. We identified 10 retinoblastomas in our cohort that lacked RB1 point mutations or indels. We performed whole genome sequencing on those 10 tumors and their corresponding germline DNA. In one of the tumors, the RB1 gene was unaltered, the MYCN gene was amplified and RB1 protein was expressed in the nuclei of the tumor cells. In addition, several tumors had complex patterns of structural variations and we identified 3 tumors with chromothripsis at the RB1 locus. This is the first report of chromothripsis as a mechanism for RB1 gene inactivation in cancer.
AuthorsJustina McEvoy, Panduka Nagahawatte, David Finkelstein, Jennifer Richards-Yutz, Marcus Valentine, Jing Ma, Charles Mullighan, Guangchun Song, Xiang Chen, Matthew Wilson, Rachel Brennan, Stanley Pounds, Jared Becksfort, Robert Huether, Charles Lu, Robert S Fulton, Lucinda L Fulton, Xin Hong, David J Dooling, Kerri Ochoa, Elaine R Mardis, Richard K Wilson, John Easton, Jinghui Zhang, James R Downing, Arupa Ganguly, Michael A Dyer
JournalOncotarget (Oncotarget) Vol. 5 Issue 2 Pg. 438-50 (Jan 30 2014) ISSN: 1949-2553 [Electronic] United States
PMID24509483 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Oncogene Proteins
  • Retinoblastoma Protein
Topics
  • Chromosome Aberrations
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Genes, Retinoblastoma
  • Humans
  • Oncogene Proteins (genetics, metabolism)
  • Retinal Neoplasms (genetics)
  • Retinoblastoma (genetics, metabolism, pathology)
  • Retinoblastoma Protein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: